CITI/CALL/VERTEX PHARMACEUTICALS/580/0.1/19.12.24

CITI/CALL/VERTEX PHARMACEUTICALS/580/0.1/19.12.24 Share Price

Warrant

DE000KH8AXT3

End-of-day quote Deutsche Boerse AG
- ^EUR	-

Current month	+85.00%
1 month	+19.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart VERTEX PHARMACEUTICALS INCORPORATED

Chart CITI/CALL/VERTEX PHARMACEUTICALS/580/0.1/19.12.24

Latest news about VERTEX PHARMACEUTICALS INCORPORATED

Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing	05-22	MT
Vertex to Participate in Upcoming June Investor Conferences	05-22	BU
ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment	05-21	MT
Vertex Pharmaceuticals Incorporated completed the acquisition of Alpine Immune Sciences, Inc. from a group of shareholders.	05-19	CI

More news

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	VERTEX PHARMACEUTICALS INCORPORATED
Issuer	Citi
WKN	KH8AXT
ISIN	DE000KH8AXT3
Date issued	24/07/2023
Strike	580 $
Maturity	19/12/2024 (211 Days)
Parity	10 : 1
Emission price	0.67 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).

Sector

More about the company